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On February 29, 2012, the Indiana University Center for Bioethics convened a one-day 
workshop of nationally recognized experts* in philosophy and ethicists, health information 
technology and systems, and health policy and health law. The purpose of the workshop was to 
solicit comments, critiques, and suggested changes to the draft of the Points to Consider 
document and its underlying ethics framework. We are grateful to the workshop participants for 
their time, interest, and input. Their involvement, however, implies neither their responsibility 
for nor their endorsement of the contents, or for how we interpreted and/or applied their input.  
 
INTRODUCTION 
Patient advocates and leaders in informatics have long proposed that patients should have 
greater ability to control the information in their electronic health record (EHR), including how it 
can be accessed by their health care providersa. The value of such “granular” controlb, as it has 
been termed, has been supported prominently in an influential report by the President’s Council 
of Advisors on Science and Technology (PCAST).(2) Recently, the U.S. Department of Health 
and Human Services (HHS) Office of the National Coordinator for Health Information 
Technology (ONC) funded several projects to study key components of EHR systems, including 
exploring ways to allow granular control.(3) 
The argument for patient granular control in clinical encountersc follows from 
developments over the past three decades aimed at supporting patient empowerment and 
                                               
a Note that in this document “health care providers” refers to physicians nurse practitioners, and physician 
assistants who provide independent clinical care. While many others are involved in patient clinical care, 
the issues raised by considering their access to the EHR raises distinct issues that will need to be 
addressed at a later date. 
b Granular control authorizes or excludes the exchange of specific pieces of information in the EHR.(1) 
c This document examines granular control in the clinical context and does not explicitly consider the 
myriad additional issues that arise from secondary uses of EHRs (as defined by HIPAA as uses beyond 
treatment, payment, and health care operations).  In particular we do not consider research uses.  This and 
all other non-treatment uses warrant separate study and analysis. 
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informed choice in the clinical encounter. (4, 5) Indeed, the argument for patient control of EHRd 
information can be seen as a logical extension of arguments for patient autonomy in decision 
making about medical treatment and research generally.(6-10) The concept of granular control also 
addresses the fundamental interest that individuals have in informational privacy. This interest is 
generally exercised, at least in part, through the ability to limit access by others to personal 
information. It is for these reasons that the promotion of Fair Information Practices (FIPs) has 
become important in many areas.(11, 12) Providing these types of controls may be seen to re-
balance the relationship between clinician and patient, to promote trust, and to enhance overall 
quality of care.(13) 
At the same time, granular control over content, access, and use of the EHR in the 
clinical context differs from other areas where respect for autonomy has been stressed, such as 
participation in a research study, where patients can exercise choice by declining to participate or 
withdrawing once enrolled. Nor is granular control of the EHR equivalent to acceptance of a 
recommended medical treatment, where patients have the right to a second opinion. In the case 
of EHRs, exercising unbridled control could have significant unintended negative consequences 
for patients and perhaps their families. For example, an individual might decide to keep his 
cardiologist from being able to see information regarding psychiatric treatment, leading the 
cardiologist to prescribe medications that interact negatively with ones that she did not know the 
patient was taking for depression. Or an individual who abuses pain killers could possibly block 
access by his family doctor to information about previous drug abuse and even data revealing 
that other providers are concurrently providing controlled medications. 
 An EHR system that provides patients with granular control of personal health 
information will only be valuable and ethically defensible if it can support the goal of patient 
empowerment while also anticipating and addressing these possible problems. Therefore, the 
goal of this document is to describe the nature of the challenges facing those who would design 
and implement a system allowing granular control for patient clinical care, as well as to outline 
specific options for addressing the problems. The challenges are especially complex due to the 
relevance of three important values: 
                                               
d This document focuses on patient control of electronic health records (EHRs), and not directly  on 
Health Information Exchanges, since EHRs provide a more likely conduit through which patients can 
directly interact. 
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(1) maximizing patient autonomy and choice about access to personal health information 
by accommodating patient control over information, 
(2) supporting quality medical care in the best interests of the patient, 
(3) valuing societal interests in an efficient health care system. 
 
These values are important in their own right, but they also derive from long-standing, 
recognized principles of bioethics(14): 
(1) Respect for autonomy (requiring respect for the decision-making capacities of 
autonomous persons); 
(2) Beneficence (requiring the promotion of the patient's best interests and overall well-
being); 
(3) Nonmaleficence (requiring the reduction  or avoidance of harm to others); and 
(4) Justice (requiring fair and appropriate distribution of benefits, risks, and costs). 
 
Describing principles and the guidance that follows, however, will not always be sufficient. 
Classic questions in medical ethics have arisen, for instance, in situations where it is impossible 
to maximize both respect for autonomy and beneficence. As with any ethical principles or 
values, these are only useful if they can be applied in specific ways to help understand and 
explicate moral issues. One often would be aided by some sort of “user’s guide” for applying 
them and accommodating conflicts among them. 
The approach adopted here is to create a “Points to Consider” document, a model that has 
been successfully used in other settings to guide policy decisions and design choices that raise 
thorny ethical, regulatory, and policy questions.(15, 16) We provide an overview of the benefits, 
risks and challenges of granular control of EHRs; a review of the key ethical principles, values, 
and Fair Information Practices that ought to guide development of an EHR that accommodates 
granular control, and offer seven detailed Points to Consider to guide decision making. 
 
 
A. The Benefits, Risks, and Challenges of Granular Control of EHRs 
Electronic health records (EHRs) are becoming common in medicine and will most likely 
become “standard of care” in the future. Massive amounts of patient data, which will soon 
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include genetic test results and other genomic data, will probably become part of a future EHR 
offering the potential to improve the quality of health care and lower its costs. Paper records can 
impede efficient sharing among health care providers, leading doctors to practice without the 
benefit of information about their patients that may exist elsewhere, resulting in duplication of 
tests and treatments and sometimes in avoidable negative outcomes.(17, 18) In addition, a 
comprehensive EHR could allow evaluation of care and outcomes in ways that are unthinkable 
with paper records, for example, by making it possible to tie reimbursement to systems of care 
and outcomes rather than to services rendered.(19-21) The federal government is funding research 
and development to improve and link EHRs and to support adoption in clinical practice through 
measures such as the Health Information Technology for Economic and Clinical Health 
(HITECH) Act of 2009. 
Quite apart from any system benefits, EHRs represent an important opportunity for more 
comprehensive involvement by patients in their care. In much the same way that informed 
consent practices changed over the past three decades to ensure that patients could better 
understand medical information being provided to them, patient-controlled EHRs are expected to 
empower patients by giving them greater control and more effective access over their medical 
information.(1) Thus, exercising control – even granular, detailed control – may have both 
instrumental and symbolic value to patients. Yet, were patient empowerment the only value 
worth supporting, granular control of EHRs would likely be reduced to a technical challenge of 
providing appropriate means for enabling patients to interface with a computer to effect their 
wishes. For patients, however, as we discuss throughout this document, granular control involves 
more than the mere technical manipulation of information; it involves expressions of their 
preferences and values about the management of personal health information, and about their 
trust in the security and integrity of EHR systems and the veracity of the data they contain.(1, 13, 
22) 
But while the power to control information offers obvious benefits, it also raises new 
concerns and intensifies old ones, perhaps most importantly related to privacy and security. 
Many have pointed out that a comprehensive EHR that can be accessed by all of a patient’s 
health care providers (which includes potentially hundreds of authorized individuals), at any 
time, may lead to undesirable consequences.(22-24) For example, some information is 
embarrassing to patients and knowing that a seemingly endless list of persons involved in their 
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clinical care may learn such information may make a patient uncomfortable, perhaps to the point 
of no longer seeking health care.(13, 22) 
Information in the EHR, such as the fact that an individual once tested positive for a 
sexually transmitted infection (STI) or was treated for depression, also may fuel irrational biases 
in providers. After all, personal health information may include intimate details about an 
individual, so the prospect of that information being available broadly can be daunting. In a 2010 
national survey, the California HealthCare Foundation found that 15% of adults said they would 
withhold information from their doctor if they knew the information would be shared, and 
another 33% said they would consider withholding information.(22) Similarly, a 2010 study by 
the Markle Foundation found that 79% of those surveyed thought patients should be able to 
review who has had access to their personal health information, and the same percentage thought 
individual patients should be able to make informed choices about how their information is 
collected, shared, and used. Over 70% of doctors also agreed with both these statements.(25) In 
multiple studies since 1990, a majority of the public has consistently expressed concerns about 
health information privacy and security.(26) 
At the same time, it is easy to envision ways that granular control could interfere with a 
physicians’ ability to provide appropriate care. A system of granular control that blocks health 
care professionals from accessing possibly lifesaving information – for example in emergency 
situations, where a patient is unconscious or incapacitated or there is limited time for discussion 
– would be particularly problematic, especially if this is information that the patient would have 
wanted them to see. Such a system would be unacceptable. Helping patients intelligently 
exercise granular control requires educating them about the meaning of the information that 
exists in the EHR and how health care providers use it.  
This can be difficult even for educated individuals, let alone for those who have limited 
education or literacy. Studies have shown that a majority of patients fail to understand simple 
medical terms appearing in medical records, such as “fracture” or “sprain,” and even college 
educated patients have trouble understanding basic statistics used in medicine.(27, 28) Further, 
there are important questions regarding how to group information in ways that would allow 
patients to make decisions regarding what information physicians can access. A system that 
would provide the finest level of granularity might list each specific piece of data (such as a 
blood test result), including the result of each observation or conclusion recorded by a physician, 
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and each test and treatment performed, and their outcomes, at each date of service. A system 
providing more generic granular control might group such data by disease type or provider type, 
and limit which potential health care providers could view each group of data. Both types of 
systems (i.e., one with the finest granularity versus one with more generic choices) may be 
ethically defensible, but their impact will differ significantly. 
 It should come as no surprise that the potential benefits and risks arising from providing 
patients with varying levels of control over personal health information has led to sustained 
discussion over the past several years. It was with this in mind that the National Committee on 
Vital and Health Statistics (NCVHS) in HHS and the PCAST took up the topic,(2, 29-31) and why a 
set of research projects have been funded by the ONC.(3) This document is being prepared as part 
of a grant to the Indiana Health Information Technology that includes support to develop a 
prototype technology for providing patients with granular control. The success of such projects 
will depend on identifying and addressing important challenges that accompany any attempt to 
provide patients with granular control. 
 
B. Principles of Bioethics and Fair Information Practices (FIPs) 
Applying bioethics principles is an important strategy to understand and address moral 
problems in health care. While differences over the content and number of principles varies 
among commentators,(32) a consensus has formed around the need to respect patient autonomy, 
promote patient well-being, minimize harm, and ensure fairness.(33-39) The main principle 
favoring patient granular control is respect for autonomy, interpreted generally as a precept to 
provide patients with the ability and opportunity to control the nature and form of the health care 
they receive, mainly by being sufficiently knowledgeable to make informed decisions. Respect 
for autonomy is the basis for informed consent and shared decision making in modern health 
care.(4) It is a logical step, then, to conclude that patients should be able control how information 
about them is accessed and disclosed. The patient can decide generally whether to go to the 
doctor, which doctor to go to, what to tell the doctor, and what tests or treatments to undergo. By 
the same reasoning, it might seem, the patient should also have a say in what data about himself 
or herself that doctor should be able to view in the health care record. 
At the same time, it is essential to acknowledge and address the risks that a patient 
exercising granular control might be exposed to by leading a health care provider to practice 
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without crucial information. Many patients may be unaware of how limiting the information 
obtained by some future physician could lead to avoidable harms. For example, information 
about a rash that a patient had one year ago could hold the clue to a diagnosis in the following  
year, and thus the patient who makes his dermatological information available only to 
dermatologists may undergo unnecessary testing, misdiagnosis, and resulting harms or even 
death. Even physicians may be unable to anticipate how one piece of information could be 
helpful later. These examples might be construed to suggest that there is a zero-sum trade off at 
work: where giving patients significant personal control (and thus maximizing their autonomous 
decision making power) can only come at the expense of promoting their own welfare (and thus 
at the expense of beneficence); or that the only way that physicians can care for and treat patients 
is to override the patient’s demonstrable interests in having control over information about them.  
Such a characterization of a stark “conflict” between the principles poorly reflects reality and is 
bad philosophy. 
At the same time, portraying respect for autonomy and beneficence as opposing 
principles is a mistake. Just as it would be presumptuous and patronizing to restrict patient 
control on grounds that they “can’t understand,” so too might offering patients too many choices 
in an unclear or unorganized way lead to confusion and thus undermine, rather than enhance, the 
exercise of autonomy.(40-42) In general, a system should be structured to help patients understand 
the possible benefits and risks of restricting access to their information and encourage them to 
reflect on their preferences and goals in seeking health care when deciding what information in 
the EHR to share and with whom. 
Beyond respect for autonomy and beneficence, the principle of justice is reflected in the 
value society places in an efficient health care system and in the appropriate distribution of 
risk and benefit. Considerations of fairness and non-discrimination and about effective and 
efficient use of resources play a role in the conversation about how to design an EHR system that 
offers granular control. There are ways that unrestricted granular control by patients could 
conceivably violate legal and regulatory requirements – such as mandated disclosure of STIs – 
that are based on public health requirements that place the community’s well-being above that of 
any one individual.(43) Providing granular control will inevitably raise tensions between what is 
respectful of individual autonomy and what is fair to the broader community. 
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In addition to these bioethics principles, any system of granular control must be 
consistent with Fair Information Practices (FIPs), a set of principles that protect 
individual informational privacy with respect to electronic record systems. FIPs were first 
introduced in 1973 and served as the basis of informational privacy laws enacted in the 
US (most notably, the Privacy Act of 1974) and omnibus privacy legislation in many 
European countries.(44, 45) The ONC has formulated a set of FIPs specifically for Health 
Information Exchanges which map well onto bioethics principles (see Appendix One).  
Our focus in this document will be on bioethics, as reflected in ethical principles and in 
FIPs, postponing closer examination of legal issues for another setting.  In addition, many 
ethical issues may exist independently of legal restrictions. 
 
C. Points to Consider 
These Points to Consider are written as a set questions that should be addressed by 
anyone involved in designing, implementing, or evaluating a system that provides patients with 
granular control. After each question, we provide a discussion of the issues involved and the 
options available for the design of a system of granular control. Each discussion includes the 
following sections: 
• a key question that frames the ethical problem; 
• a description of the challenges involved in answering the question; 
• a list of options available to answer the question; 
• a discussion of the issues and applicable principles of bioethics and FIPs that each option 
generates. 
We aim to avoid identifying a single option or approach as the “correct” response to the question 
involved in each Point. Instead, the discussion that follows each Point is meant to guide 
designers through the issues they must face in any system of granular control.  This Points to 
Consider document aims to present options that may be available in many different types of 
EHRs, given the variety that exist across the country, but it is possible that some described 
options may not be possible for some EHRs.  In addition, as EHRs develop over time, some 
Points may need to be revisited in the future in light of technological or policy developments. 
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1. How will the system make transparent the uses and flows of clinical information so that 
patients can make informed choices about disclosing/restricting their information? 
(Applicable bioethics principle: respect for autonomy; 
Applicable FIPs: openness and transparency; individual choice) 
 
a. Challenge 
This question encompasses at least three interconnected issues: 
i. How will patients be told about the flows, uses, and users of their health information? 
ii. How will patients learn what information is contained in their EHR so they can 
appreciate what they are granting access to – a prerequisite for individual choices to be 
meaningful? 
iii. How will patients be assisted in understanding the meaning of the medical information in 
their EHR (e.g., terminology used in pathology, laboratory, radiological tests/reports)? 
 
The challenge is to make it possible for patients to understand enough about the EHR so that 
they can make good decisions about access to their personal information, even if they do not 
fully understand the clinical information or all the possible uses of the EHR. 
It will be important to decide how patients should be informed about the flows and uses 
of their clinical information. And such descriptions can be very complex. For instance, patients 
could be told that their clinical information might be seen by myriad people (including clinicians 
of many different types, nurses, public health authorities, dieticians, home health care providers, 
and physical, rehabilitation, or respiratory therapists) at many different institutions (including 
laboratories, pharmacies, long-term care facilities, hospitals, and ambulatory care centers). 
Unless a patient is allowed to see what is in their own EHR, it will be difficult (perhaps 
profoundly so) to decide about any access restrictions. Unless they understand what information 
is in the EHR their decisions cannot be fully informed. 
 
b. Options for Providing Information to Patients 
i. Provide no education regarding what information exists in the EHR or the flow 
and uses of information besides the required, and fairly general, Notice of Privacy 
Practices. Patients will utilize whatever additional understanding they happen to 
have, including any misunderstanding, in exercising granular control. 
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ii. Provide educational materials for patients to review before exercising granular 
control. These materials can be more or less specific or customizable to the 
literacy and interests of different patients. 
iii. Give all patients access to a trained educator or practitioner who can brief or tutor 
them on the EHR. 
 
c. Issues and Principles 
 Option (i) appears to fail to respect the principle of respect for autonomy. Patients who do 
not understand the information in their EHR, or are not told who may use it, may make choices 
about access that have little to do with their true preferences. For example, consider a patient 
who wishes to withhold from their endocrinologist medical information collected by a 
dermatologist believing (incorrectly) that the information from one specialist is not needed by 
the other. Or perhaps the patient was concerned about an embarrassing fact being disclosed. In 
the absence of understanding why it would be in their medical best interest to have this 
information shared, the patient may exercise choice, but may hardly be considered to be 
expressing their autonomy. Option (i) likely fails to respect the principle of beneficence. By 
leaving patients uneducated regarding the issues involved in exercising granular control, this 
approach threatens the well-being of patients who choose to restrict access of health care 
practitioners. While some patients will have adequate information to make informed choices, 
designing a system using Option (i) here appears to threaten the well-being of many who are 
uneducated or unaware. If, on the other hand, patients are helped to understand the need for 
many specialists to have access to the same information, it may be possible for patients to 
exercise their autonomy and receive medical care that serves their best interests. 
 Option (ii) is more attractive than Option (i) insofar as it is more consistent with the 
principles of respecting autonomy (by providing more information to enable informed choice) 
and promoting beneficence (by encouraging more engagement with health care providers). 
However, there are significant challenges to determining what sort of educational materials to 
provide, their format, how to tailor them to different levels of ability and interest, and how to 
evaluate the effects. Each patient would have to get at least a baseline of information that 
accurately describes the potential risks involved in restricting access to information but does not 
do so in such a way that unfairly or misleadingly dissuades patients from ever exercising 
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granular control. Similar considerations apply to whether materials are provided at the 
physician’s office, what format those materials are in, and who provides them to the patient. 
Option (iii) may seem the most attractive option given that it would highly promote both 
respect for autonomy and beneficence. Indeed, face-to-face counseling could supplement Option 
(ii)(46); however, as a matter of justice, and in particular the fair distribution of overall resources, 
the availability of and access to trained individuals may be a cost the health care system is not 
prepared to cover. 
 
2. How will the system structure the array of choices patients can specify for disclosure 
and non-disclosure of their clinical information?  
(Applicable bioethics principle: respect for autonomy; 
Applicable FIPs: openness and transparency; individual choice) 
 
a. Challenge: 
One way to envision how a system would offer granular control to patients is by listing 
the sort of information that exists in the EHR, possibly grouped in various ways, and asking 
whether specific providers may access that data. A central question for any system to provide 
patients with granular control is whether and how to group clinical information when offering 
patients the choice of restricting access to that information by health care providers. A separate, 
but equally critical question, is whether and how to group providers who may be granted access 
(or not) to specific parts of the patient’s EHR. For instance, patients may be given the option of 
identifying providers individually (e.g. by name), or by practice group, institution, or specialty. 
The options presented under this Point (Section b., next) involve choices regarding 
whether and how to focus on the question of regarding how to group the information in the EHR 
when offering patients the option of determining access to that information by providers. We do 
not explicitly discuss the options for grouping the list of possible providers who may access each 
of those pieces of data (or types of data), although we discuss this issue in the section on Issues 
and Principles (Section c.), below. 
 
b. Options for Presenting Personal Health Information 
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i. List each specific piece of information, including the result of each observation or 
conclusion recorded by a physician, and each test and treatment performed, and their 
outcomes, at each date of service. Then the patient could decide, for each piece of 
information, whether each potential health care provider could view that piece of 
information. 
ii. Group information in various ways, reducing the granularity of patient control, for 
instance grouping according to: 
a. Date of service: e.g., all data collected on January 16, 2011, 
b. Provider: e.g., all data, including ordering of tests by providers, 
c. Disease: e.g., all data relating to diabetes, 
d. Treatment: e.g., all data related to a specific prescription drug or treatment plan, 
e. Area of medical care: e.g., all data related to endocrinology, or 
f. Sensitivity of the information, as recommended by the NCVHS: e.g., in 
predetermined/predefined categories like reproductive health, mental health, 
substance abuse, domestic violence, and genetic information.(31) 
iii. Present choices that encompass a compromise between Options i and ii above, where 
the system allows granular control choices at a predetermined standardized level of 
granularity (as in ii, above), but considers accommodating additional requests for 
restrictions on a non-standardized basis. 
 
c. Issues and Principles 
Option (i) provides control at the finest level of granularity. In so doing, it provides the 
greatest degree of patient control and empowerment. At the same time, this approach could be 
the most challenging to comprehend by patients. A list of each individual note, prescription, test 
result, etc., issued on each interaction with the health care system would be understandably 
overwhelming. How would a patient decide whether his cardiologist needs to have access to the 
complete blood count (CBC) drawn in January 2012 by his internist? Is the choice different for 
the complete metabolic panel (CMP) drawn on the same day? How about the chest x-ray that 
was performed? Systems that provide an abundance of poorly defined choices to patients fail to 
respect autonomy. Maximizing choices is not necessarily a way of maximizing patient 
autonomy.(47) Option (i) might also lead to negative outcomes and thus fail to respect the 
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principle of beneficence. A patient with too many choices – especially one without the benefit of 
education or transparency – may be unable to act in their own best interest. Where an informed 
patient may be able to manage well with finely granular choices, other patients may be 
overwhelmed. Option (i) would thus be most appropriate when accompanied by the kind of 
detailed education described in Point 1 above. 
 Option (ii) could reduce the risks in Option (i) by grouping the information in various 
ways. The trade off is that any such grouping reduces the ability of a patient to make the most 
fine discriminations about the use of their information, but does so in a way that limits the type 
of control into more manageable chunks. For instance, if a system was organized by Option (ii.a) 
a patient could not choose to restrict access by his cardiologist to one test (e.g., his HIV test, 
perhaps done on January 16, 2012) without also restricting access to other tests (e.g., his chest X-
ray). Thus, grouping information according to Option (ii) reduces the number of choices 
available to the patient, but in so doing, it promotes patient autonomy by providing choices that 
are more comprehensible (and through which the patient could best express his or her desire for 
privacy weighed against possible negative consequences), and serves to promote their clinical 
best interests (beneficence). 
That said, Option (ii) can be critiqued due to its failure to provide the sort of fine granular 
control that some patients may desire. For example, under this system, there may be no 
mechanism to restrict access to a single note or set of tests or treatments, as is provided by 
Option (i). 
Option (iii) attempts to accommodate patients who will desire to make some access 
restriction choices at a coarser level of granular control, as in Option (ii), and others at a finer 
level of control, as in Option (i). This option could be seen as maximizing patient autonomy by 
providing the ability for the patient to determine the level of granularity that he or she desires for 
a specific situation. At the same time, this represents a level of complexity – asking patients to 
determine the level of granularity as well as the specific questions about access – that may be 
overwhelming. And a system that overwhelms patients with complexity will fail to fulfill the 
goal of respecting autonomy or beneficence. 
The discussion so far has focused on the granularity of the control that patients may 
exercise for their data, i.e. on a finer level (e.g., by specific observation or test result) or more 
generally (e.g., by disease). A related issue involves the granularity of control over which 
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patients can define which providers can view a given piece of data. The finest level of 
granularity for this determination would be for the patient to define, for each specific, named 
provider whether he or she can view the data in question. But providers could also be grouped: a 
patient may decide what can be viewed by all the providers in one practice group, or who will 
see the patient in a certain time period, or in one specialty. Questions related to how patients will 
define which providers can have access to specific parts of the patient’s EHR are of course 
central to a system of granular control. In fact, a patient may choose to give specific providers 
access to all the information in the EHR, or at least all the information resulting from a type of 
care, expressing trust in those providers or their institution. 
This possibility is consistent with the idea that patients might be more able to express 
their autonomy by focusing on the individuals and institutions that would use or access their 
information rather than the information itself. This is consistent with the notion that patients are 
prepared to forgo some control when they believe that others will responsibly use the 
information in a trustworthy manner.(48) 
It is likely that different levels of granularity, regarding data or providers, may be 
appropriate for different patients or situations. It is unlikely that a “one size fits all” approach to 
granular control could accommodate their desires to restrict their health information. The 
question is whether the system should be designed to accommodate what might be maximally 
desirable in terms of patient autonomy (bearing in mind that a broad array of choices may not 
maximize autonomy), or be designed to provide fewer choices for granular control, but which 
may contribute more to an efficient system of health care delivery. And, clearly, the possible 
level of granularity may be limited by what is technically feasible. This is why we emphasize 
that the use of the Points to Consider should not be approached as a “one time only” exercise, but 
also should be used to evaluate how well the issues addressed are being managed in an ongoing 
process.  
 
3. How will technologically and/or medically unsophisticated patients, or those with other 
challenges, exercise their choices for granular control of their information? 
(Applicable bioethics principle: respect for autonomy; 
Applicable FIP: individual access) 
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a. Challenge 
This question addresses issues not only of technological literacy (such as understanding 
how computers collect and store information, how data might be encrypted, etc.), but medical 
literacy, reading and English literacy. It will be important to consider different methods of 
recording patients’ choices, given that the patient population spans all technological skill levels, 
as well as all physical, language, and mental abilities. Finding a “one size fits all” solution to 
register access preferences is unlikely to accommodate all patients. On the other hand, it could 
constitute a significant expenditure to accommodate each patient’s specific needs. That said, 
there is an ethical obligation to ensure that the exercise of rights or privileges is not dependent on 
one’s ability to read/speak English, understand medical terminology, or be able to use a 
computer. 
 
b. Options for Exercising Choice 
Because the overall goal is to allow patients to express and record their information-
sharing preferences, it is important that the options for doing so span a reasonably broad range of 
patient capabilities. In this case, that may mean that the system should be designed to 
accommodate various input methods. For instance, the system could: 
i. Provide an electronic input option for choices to be recorded by the patient (and/or his 
representative) only, and be available in a variety of languages (at least English and 
Spanish); 
ii. Devise a two-step process for input, giving patients a paper form containing the choices 
available, which is then taken by a medical staff member to be recorded in the electronic 
system; 
iii. Provide other means for patients to learn about their options and indicate their 
preferences, for instance through discussion with a medical staff member (e.g., for those 
who have difficulty reading, or are sight-challenged) who would then record the patient’s 
choices and preferences. 
 
c. Issues and Principles 
The options are far from exclusive: while a computer-based system would be desirable 
for those who are able to use it effectively, patients who are not (for one of the reasons listed) 
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should be accommodated in some other way (as in Options ii and iii). The ethical basis for this 
variety is based on the principles of ethics and fair information practices that support a system of 
granular control for all patients, independent of their abilities to use a computer. In addition, it 
would seem that the sort of educational activities discussed under Point 1 would need to be 
adjusted, if possible, based on the abilities and desires of patients. 
 Finally, making the system of granular control accessible to those who speak languages 
other than English makes good sense. Although HIPAA does not require health care providers or 
facilities to furnish translations of their Notice of Privacy Practices document, in many instances 
Title IV of the Civil Rights Act of 1964 might require translations. Indeed, there is a career 
subspecialty for medical translators/interpreters who provide translation services to patients with 
limited English proficiency.(49) 
 
4. How will the system inform providers of a patient’s preferences for data 
access/restrictions? 
(Applicable bioethics principles: respect for autonomy, beneficence; 
Applicable FIP: Collection, use, and disclosure limitation) 
 
a. Challenge 
For providers to act in the patient’s best medical interest (thereby promoting beneficence) 
they need to know all relevant information about the patient. Incomplete information may mean 
an incorrect diagnosis or an inadequate treatment plan. In the worst case scenario, a patient who 
opts out of having an EHR may put themselves in the position of denying physicians access to 
important information. On the other hand a patient who’s EHR is incomplete presents challenges 
for accurate diagnosis and treatment. 
But providers also have an interest in building and maintaining a relationship of trust, one 
in which patients have a role in deciding about their care and about the use of information about 
themselves stored in the EHR. The trust relationship, however, goes both ways: just as a patient 
is entitled to know what the reasons are that a provider is recommending a treatment, so is a  
provider entitled to believe s/he deserves to be informed when information is being withheld. In 
addition, a provider might want to understand how and why patients decide to restrict and/or 
share access to their medical information. 
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b. Options 
i. When a physician views the patient’s EHR, the system will specify which information 
exists and is accessible, and which information exists but is being restricted due to the 
patient’s prior preferences and privacy settings. 
ii. When a physician views the patient’s EHR, the system will only display the information 
that is allowed by the privacy settings, without disclosing the existence of other 
information that is subject to access restrictions. 
iii. When a physician views the patient’s EHR, a broad statement that information has been 
restricted would be provided without specifying which types of information are not 
accessible. 
 
c. Issues and Principles 
Some designers of a system of granular control might favor Option (i), arguing that even 
though patients have a right to restrict who sees their data, doctors should be informed when 
information is present in the EHR but not being displayed. Informing physicians of the type of 
information that is restricted would allow physicians to discuss those preferences with patients 
and discuss the provider’s viewpoints on restricted access. The goal of this approach would be to 
inform physicians that they are practicing without all the information contained in the EHR; 
arguably, though, this option may violate the patient’s very point in requesting privacy. 
Moreover, some federal and state regulations (e.g., 42 CFR Part 2) require confidentiality for 
sensitive medical information (e.g., information maintained and shared by federally supported 
substance abuse programs), and do not allow providers to give notification that the information 
exists when sending a patient’s record without the sensitive information. 
Option (i) might also help avoid the problem of a physician becoming concerned about 
why a specific test or a recommended treatment was not ordered in the past. For example, if the 
physician knows that the patient had a broken bone in the past, but is being told by the radiology 
section of the EMR that there is no information about an x-ray being performed, he may be 
uncertain as to whether the information exists but is restricted, or does not exist at all. 
At the same time, one could argue against Option (i), and for Options (ii) or (iii), by 
pointing out that there are very few, if any, circumstances in which doctors now practice 
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medicine with full information – certainly not with a paper-based record system. Further, given 
that patients are always ultimately in control of the information they decide to communicate to 
(or withhold from) their providers, one could conclude that a patient’s decision to restrict access 
to data in the EHR need not be disclosed. 
If Option (i) is chosen, another decision would involve whether to disclose that the 
restricted access is due to the patient’s choice, or if the cause should be left vague. Vagueness in 
this area has the advantage of perhaps diminishing the chance that the physician will directly 
pressure the patient for access or refuse to treat unless provided access. At the same time, 
physicians seeing this notification, no matter how vague, may intuit the cause. 
 Option (ii) has the advantage of avoiding physician pressure on the patient to reveal 
information the patient does not want revealed, or of the physician treating the patient with 
suspicion (or even annoyance) over knowing some information is being restricted. This option 
also allows the patient to maintain the access controls s/he prefers, although it might also oblige 
providers to make additional inquiries of patients. 
Option (iii) would have a similar effect on physicians, in that they would be alerted to the 
fact that not all information available in the EHR was available to them. It might provide the 
opening for a more detailed conversation with the patient, or it might inhibit the ongoing 
relationship. 
 
5. Under what circumstances/conditions will the system allow health care providers to 
access patient data in ways that may over-ride stated preferences for granular control? 
(Applicable bioethics principles: respect for autonomy, beneficence) 
 
a. Challenge 
A situation in which the benefits of the EHR are perhaps best displayed is when an 
unconscious patient is brought into the emergency room, and doctors are able to use the EHR to 
find out that the patient has a certain disease or is taking a certain drug. Having access to an EHR 
in this sort of case can save the patient’s life. Reality is perhaps rarely this simple: emergency 
room personnel often do not have time to refer to the EHR until after a patient has been 
stabilized. In any event, the ethical question in an emergency situation is whether the patient’s 
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data should be accessed in ways that might override their prior stated preferences for limiting 
access to the EHR, and if so, how the facts of that access should be accounted for or tracked.  
It is also possible that even in non-emergency situations, health care professionals could 
have good reasons to want to override restrictions on access to information in the EHR; for 
example, a patient may present to an emergency room incapacitated and unable to consent to 
disclosing all of their health information. In another example, a physician who is considering 
prescribing a controlled medication, but has not been given access to a patient’s full record, 
might wish to override some limits. The issue in this Point is whether there are circumstances in 
which, during an emergency or typical clinical encounter, a patient’s preferences might need to 
be overridden, and what those circumstances might be. It should be pointed out that federal 
regulations (42 CFR § 2.51(a)) permit disclosures of protected substance abuse treatment 
information without patient consent in a medical emergency, as long as the emergency poses an 
immediate threat to the patient’s health and requires immediate medical intervention. Similarly, 
disclosures of protected substance abuse treatment information without patient consent are 
permitted to the Food and Drug Administration (FDA) when it asserts that a patient’s health 
might be in jeopardy due to an error in the labeling, manufacture, or sale of a product under 
FDA’s jurisdiction, and the information is only used to notify patients or physicians of the 
potential dangers (42 CFR § 2.51(b)).  Similar emergency exceptions exist within state laws that 
restrict the disclosure of certain types of health information. 
 
b. Options 
i. Never allow providers to override stated patient preferences for granular control, even in 
emergency situations where access to restricted data in the EHR could save the patient’s 
life. 
ii. Allow providers to override stated patient preferences for granular control only in 
emergency situations, where access to data could be life saving, but not in other serious 
but non-life-threatening situations, where the patient could be asked for access 
permission. 
iii. Override patient preferences in non-emergency situations, but only under pre-determined, 
specified circumstances. 
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iv. Override patient preferences in non-emergency situations in any circumstances where the 
provider believes the patient’s best interest will be served by accessing otherwise 
restricted data, with a requirement that a justification be added to the patient’s EHR 
afterwards. 
 
c. Issues and Principles 
 The ethical principle of respect for autonomy motivates Option (i). In contrast, Option (ii) 
is motivated by the ethical principle of beneficence, based on the argument that the welfare of 
the patient outweighs the importance of respecting the patient’s stated preferences. 
 Complicating this way of parsing the ethics is the possibility that most patients would 
want their stated preferences for granular control to be overridden in emergency or life-
threatening situations (or that emergency situations should be exempt from their stated 
preferences). From this perspective, even Option (ii) could be supported by the principle of 
respect for autonomy. 
At the same time, a justification of Option (ii) based on respect for autonomy might 
militate for asking patients ahead of time, when they are stating their desire for granular control, 
how they wish doctors to act in emergency situations. At the same time, even if a patient says 
that he or she wants access restrictions to remain in place, even in life threatening situations, it 
may be hard to believe that this truly represents a patient's true desires. 
Under Option (iii) a set of non-emergency situations should be specified in advance 
under which preferences will be overridden, with a specific rationale for each. The ethical 
justification for taking the time and effort to predetermine these circumstances is that honoring 
patients’ preferences is still the primary objective, but also taking into account clinical situations 
in which the patient’s best clinical interests will be served by overriding their preferences only 
when absolutely necessary. A new patient coming to a doctor for pain medications might be such 
a situation. 
Option (iv) takes Option (iii) further, but instead of having a pre-determined set of non-
emergency circumstances in which preferences are overridden, the provider makes that 
determination at the time of the clinical encounter. This would also encompass the provider who 
prefers to treat only patients who have not restricted access to any part of their record. Many 
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would argue that this option would unacceptably violate the autonomy of patients and would 
make any system of granular control almost pointless. 
Under all of these options, it is ethically necessary in order to fulfill the obligation of 
respect for persons, to inform patients of whatever option is implemented. Moreover, patients 
should be informed before such a circumstance might arise. For instance, the provider should 
have a stated policy covering their approach under this circumstance (whether it is Option i, ii, 
iii, or iv); if Option iii, a general description of the type of specific reasons patient choices would 
be overridden should be provided to patients; and if Option iv, a clear notification to patients 
should be provided up front, so they can determine whether they accept the doctor’s policy, or 
whether they prefer to seek treatment elsewhere. Finally, Options ii, iii, and iv could be coupled 
with a system for auditing any such overrides to evaluate the severity of the situation and the 
reasonableness of the provider’s decision to override patient access preferences.  Indeed, 42 CFR 
§ 2.51(c) requires that immediately following a disclosure of covered substance abuse treatment 
information made for a medical emergency, the name and affiliation of the medical personnel to 
whom the disclosure was made, the individual making the disclosure, the date and time of the 
disclosure, and the nature of the emergency that required the disclosure be documented.  
 
6. How will patients be told about mandatory reporting requirements (e.g., public health, 
gunshots, abuse, disease registries, etc) and their impact on granular control? 
(Applicable bioethics principles: respect for autonomy, beneficence; 
Applicable FIP: openness and transparency, individual choice) 
 
a. Challenge 
Federal and/or state laws require that medical information pertaining to a possible 
criminal activity (e.g., child abuse or neglect, domestic violence, and gunshot wounds) be 
reported to the appropriate authorities. Similarly, when a patient with a communicable disease 
presents for treatment (whether for that condition or something unrelated), state and/or federal 
laws/regulations often require reporting of identifiable health information about the disease. 
Because of this, patients will not be able to exert granular control on such information. Any 
system of granular control must anticipate and address this issue. For instance, it may seem 
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appropriate to inform patients of the requirements for disclosure and the ways in which stated 
desires for granular control would be over-ridden by such requirements. 
 
b. Options for Disclosing Mandatory Reporting Requirements 
Legal requirements must, of course, be respected once a diagnosis of a reportable disease 
is made. However, a system of granular control might inform patients of the existence of such 
legal requirements and how they will impact disclosure, in the following ways: 
i. Do not explicitly inform patients regarding legally mandated reporting requirements (i.e., 
that irrespective of her desire to restrict disclosure, some circumstances mandate 
disclosures). 
ii. Provide a general explanation that there may be legal reasons why some personal health 
information must be disclosed, but do not detail those reasons. This could include, for 
example, putting posters in patient intake areas in clinics, physicians’ offices, hospitals, 
outpatient facilities, etc., or very general statements in Notices of Privacy Practices given 
to patients. 
iii. Inform patients more specifically what sort of situations would require disclosure of 
personal health information to public health authorities and/or law enforcement (e.g., 
STIs, communicable diseases, epidemic and/or pandemic outbreaks, abuse, gunshots, 
suspected bioterrorism), and what sort of information would be disclosed (e.g., name, 
address, diagnosis, etc.). 
 
c. Issues and Principles 
The HIPAA Privacy Rule requires that Notices of Privacy Practices describe the ways 
that the providers are allowed to use and disclose health information, including mandatory 
disclosures, although notices might not distinguish between what information disclosures are 
mandatory versus those that are otherwise allowed without patient authorization.(50) So, for some 
organizations, Option (i) could represent the status quo. Ethically, however, one could argue that 
it is more appropriate to at least provide patients with some details about such requirements, 
especially if one is also offering choices regarding granular control. That leaves Options ii and 
iii, which disclose varying degrees of detail about mandatory reporting requirements. 
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At the same time, such information, and the more specific information provided under 
Option (iii) might dissuade a small minority of patients from seeking treatment for a reportable 
condition. One might argue that allowing such choices by patients reflects respect for autonomy, 
though that could be questioned in at least some situations. (Is it ethical to make sure a parent 
who is abusing their child knows the danger of bringing that child to the emergency room? How 
about a patient who has been shot?) If a practitioner has a reason to suspect that a particular 
patient might not seek treatment, or might pose an imminent risk to the public health and/or 
safety, then under the ethical principle of beneficence (doing what is best for the patient, and in 
this case, what may also be best for a child or society at large), the provider might wish to 
withhold information about the specific nature of mandatory disclosures from the patient. 
However, such cases should be the exception, not the rule. 
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Appendix One 
 
Fair Information Practices for Health Information Exchange (ONC’s FIPs) mapped with 
Bioethics Principles 
 
Individual Access  
• Respect for autonomy 
Individuals should be provided with a simple and timely means to 
access and obtain their individually identifiable health information in a 
readable form and format.  
 
Correction  
• Respect for autonomy 
• Beneficence 
Individuals should be provided with a timely means to dispute the 
accuracy or integrity of their individually identifiable health 
information, and to have erroneous information corrected or to have a 
dispute documented if their requests are denied.  
 
Openness and Transparency  
• Respect for autonomy 
There should be openness and transparency about policies, procedures, 
and technologies that directly affect individuals and/or their 
individually identifiable health information.  
 
Individual choice  
• Respect for autonomy 
Individuals should be provided a reasonable opportunity and capability 
to make informed decisions about the collection, use and disclosure of 
their individually identifiable health information.  
 
Collection, Use, and 
Disclosure Limitation  
• Nonmaleficence 
Individually identifiable health information should be collected, used, 
and/or disclosed only to the extent necessary to accomplish a specified 
lawful purpose(s) and never to discriminate inappropriately.  
 
Data Integrity and Quality  
• Nonmaleficence 
• Beneficence 
Persons and entities should take reasonable steps to ensure that 
individually identifiable health information is complete, accurate and 
up-to-date to the extent necessary for the person’s or entity’s intended 
purposes and has not been altered or destroyed in an unauthorized 
manner.  
 
Safeguards  
• Nonmaleficence 
• Beneficence 
Individually identifiable health information should be protected with 
reasonable administrative, technical, and physical safeguards to ensure 
its confidentiality, integrity, and availability and to prevent 
unauthorized or inappropriate access, use or disclosure.  
 
Accountability  
• Nonmaleficence 
• Beneficence 
 
These principles should be implemented, and adherence assured, 
through appropriate monitoring and other means and methods should 
be in place to report and mitigate non-adherence and breaches.  
 
(Source: Office of the National Coordinator for Health Information Technology. Nationwide 
privacy and security framework for electronic exchange of individually identifiable health 
information. ONC. December 15, 2008) 
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